Allergy and Immunology · Pittsburgh, PA
NPI
1104039783
Since 2007
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
3459 5th Ave, UPMC Montefiore, Nw628; Asthma Institute
Pittsburgh, PA, 15213
Phone (412) 692-2139
Groups this clinician bills Medicare through
Medicare paid, 2024
$9,522
427 services
Medicare patients, 2024
72
Average age 67
Drug cost, 2024
$1.7M
1,274 prescriptions
Company payments, 2025
$2,174
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Merritt Fajt was code 99214 (office e&m - established), 44 times for 33 patients. In total Merritt Fajt billed 427 services in 16 codes, and Medicare paid $9,522.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 44 | 33 | $70.14 | $3,086 |
| 99214 Office E&M - Established | Office | 40 | 25 | $84.42 | $3,377 |
| 94060 Pulmonary Function Testing | Facility | 13 | 11 | $5.89 | $76.58 |
By year: 2022 $13K for 554 services; 2023 $9,306 for 514 services; 2024 $9,522 for 427 services.
Medicare prescription drug claims, 2024
In 2024, the drug Merritt Fajt prescribed most often to Medicare patients was Levocetirizine Dihydrochloride, with 188 prescriptions and refills. In total Merritt Fajt wrote 1,274 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levocetirizine Dihydrochloride Generic | 188 | 237 | 29 | $2,996 |
| Montelukast Sodium Generic | 179 | 327 | 37 | $2,874 |
| Famotidine Generic | 160 | 256 | 34 | $2,426 |
| Azelastine Hcl Generic | 132 | 168 | 31 | $2,800 |
| Flunisolide Generic | 72 | 84 | 19 | $3,277 |
| Fluticasone Propionate Generic | 65 | 99 | 18 | $806 |
| Xolair Omalizumab | 63 | 63 | Under 11 | $215K |
| Cromolyn Sodium Generic | 44 | 51 | 11 | $4,275 |
| Breo Ellipta Fluticasone/Vilanterol | 42 | 67 | Under 11 | $26K |
| Epinephrine Generic | 27 | 27 | 23 | $6,553 |
| Spiriva Respimat Tiotropium Bromide | 27 | 27 | Under 11 | $13K |
| Xembify Immune Globulin,gamma(Igg)klhw | 26 | 26 | Under 11 | $104K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 22 | 24 | Under 11 | $3,976 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 20 | 40 | Under 11 | $24K |
| Ipratropium Bromide Generic | 20 | 33 | Under 11 | $883 |
Brand drugs: 309 claims; generic drugs: 965 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Merritt Fajt $2,174 ($2,174 in general payments such as food, travel and fees) from 6 companies. The largest payer was Genzyme Corporation with $673.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.